Drug · DIN 02379511
SIMVASTATIN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since December 15, 2015; first marketed March 1, 2013.
- Drug Identification Number (DIN)
- 02379511
- Company (DIN owner)
- Bentec Pharma IncSaskatoon, Saskatchewan, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Simvastatin C10AA01
- Class
- Human
- Record last updated
- June 18, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SIMVASTATIN | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 22, 2012: NOC 13055Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named SIMVASTATIN
- DIN 02284723 · Marketed
- DIN 02284731 · Marketed
- DIN 02284758 · Marketed
- DIN 02284766 · Marketed
- DIN 02284774 · Marketed
- DIN 02386291 · Marketed
- DIN 02386305 · Marketed
- DIN 02386313 · Marketed
- DIN 02386321 · Marketed
- DIN 02386348 · Marketed
- DIN 02342456 · Cancelled Pre Market
- DIN 02342464 · Cancelled Pre Market
- DIN 02342472 · Cancelled Pre Market
- DIN 02342480 · Cancelled Pre Market
- DIN 02342499 · Cancelled Pre Market
- DIN 02343142 · Cancelled Post Market
- DIN 02343150 · Cancelled Post Market
- DIN 02343169 · Cancelled Post Market
- DIN 02343177 · Cancelled Post Market
- DIN 02343185 · Cancelled Post Market